CURRENT TREATMENT PATTERNS AND SURVIVAL IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: FINDINGS FROM A BRIEF SURVEY OF EUROPEAN PHYSICIANS

被引：0
|
作者：
Davis, K. L. [1 ]
Lin, H. M. [2 ]
Zhang, S. [3 ]
Kaye, J. A. [4 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Millennium Pharmaceut Inc, Cambridge, MA USA
[3] Takeda Pharmaceut Int Inc, Deerfield, IL USA
[4] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1284
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN186
引用
收藏
页码：A1221 / A1221
页数：1
相关论文
共 50 条
  • [31] Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study
    Dhanasiri, Sujith
    Hollier-Hann, Georgia
    Stothard, Catherine
    Dhanda, Devender S.
    Davies, Faith E.
    Rodriguez-Otero, Paula
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 1983 - +
  • [32] Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble
    Vij, Ravi
    Chen, Clara
    Popov, Sergey
    Durie, Brian
    Cook, Gordon
    Zyczynski, Teresa
    Davis, Catherine
    Goldschmidt, Hartmut
    BLOOD, 2017, 130
  • [33] Duration of Treatment of Multiple Myeloma Regimens in Patients with Relapsed or Refractory Multiple Myeloma: Findings in US Clinical Practice Settings
    Potluri, Ravi
    Kanakamedala, Hemanth
    Chen, Clara
    Yasenchak, Christopher A.
    Ranjan, Sandip
    Papademetriou, Eros
    Bhandari, Hitesh
    Mann, Jasdeep
    Davis, Catherine
    BLOOD, 2017, 130
  • [34] Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
    Moreau, Philippe
    Kumar, Shaji K.
    Miguel, Jesus San
    Davies, Faith
    Zamagni, Elena
    Bahlis, Nizar
    Ludwig, Heinz
    Mikhael, Joseph
    Terpos, Evangelos
    Schjesvold, Fredrik
    Martin, Thomas
    Yong, Kwee
    Durie, Brian G. M.
    Facon, Thierry
    Jurczyszyn, Artur
    Sidana, Surbhi
    Raje, Noopur
    Donk, Niels van de
    Lonial, Sagar
    Cavo, Michele
    Kristinsson, Sigurdur Y.
    Lentzsch, Suzanne
    Hajek, Roman
    Anderson, Kenneth C.
    Joao, Cristina
    Einsele, Hermann
    Sonneveld, Pieter
    Engelhardt, Monika
    Fonseca, Rafael
    Vangsted, Annette
    Weisel, Katja
    Baz, Rachid
    Hungria, Vania
    Berdeja, Jesus G.
    da Costa, Fernando Leal
    Maiolino, Angelo
    Waage, Anders
    Vesole, David H.
    Ocio, Enrique M.
    Quach, Hang
    Driessen, Christoph
    Blade, Joan
    Leleu, Xavier
    Riva, Eloisa
    Bergsagel, Peter Leif
    Hou, Jian
    Chng, Wee Joo
    Mellqvist, Ulf-Henrik
    Dytfeld, Dominik
    Harousseau, Jean-Luc
    LANCET ONCOLOGY, 2021, 22 (03): : E105 - E118
  • [35] HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH DIFFERENT TREATMENT MODALITIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN FOUR EUROPEAN COUNTRIES: FINDINGS FROM PREAMBLE
    Goldschmidt, H.
    Chen, C.
    Vij, R.
    Davis, C.
    Moreau, P.
    VALUE IN HEALTH, 2019, 22 : S479 - S479
  • [36] Patterns of Medication Use in Patients with Relapsed and/or Refractory Multiple Myeloma
    Hagiwara, May
    Moynahan, Aaron
    Cong, Ze
    Chen, Yaozhu J.
    Duchesneau, Emilie
    Hurley, Dana
    Delea, Thomas E.
    BLOOD, 2015, 126 (23)
  • [37] Emerging therapies for the treatment of relapsed or refractory multiple myeloma
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Anderson, Kenneth C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (01) : 1 - 15
  • [38] The role of elotuzumab in the treatment of relapsed or refractory multiple myeloma
    Comeau, Jill M.
    Kelly, Katherine
    Jean, Gary W.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (02) : 55 - 66
  • [39] Prolonged treatment with lenalidomide in relapsed and refractory multiple myeloma
    Franco C.A.
    Palomera L.
    Arredondo J.J.R.
    Sánchez J.M.
    Advances in Therapy, 2011, 28 (Suppl 8) : 14 - 19
  • [40] An evaluation of linvoseltamab for treatment of relapsed/refractory multiple myeloma
    Avigan, Zachary M.
    Rattu, Mohammad A.
    Richter, Joshua
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (03) : 221 - 228
12345